UBS Initiates Coverage On PROCEPT BioRobotics with Buy Rating, Announces Price Target of $62
Benzinga Newsdesk 11 months ago
NewsPrice TargetInitiationAnalyst Ratings
UBS analyst Danielle Antalffy initiates coverage on PROCEPT BioRobotics (NASDAQ:PRCT) with a Buy rating and announces Price Target of $62.
UBS analyst Danielle Antalffy initiates coverage on PROCEPT BioRobotics (NASDAQ:PRCT) with a Buy rating and announces Price Target of $62.